Evidence map›Paper›PMID 34668463›Full record

ArticleInternational journal of circumpolar health2021

Hepatitis B virus elimination status and strategies in circumpolar countries, 2020.

Celia Haering, Brian McMahon, Aaron Harris, Nina Weis, Josefine Lundberg Ederth, Maria Axelsson, Sigurdur Olafsson, Carla Osiowy, Kristina Tomas, Signe Bollerup and 5 more

Abstract read
In one paragraph

Article in International journal of circumpolar health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Celia HaeringUniversity of California San Francisco School of Medicine, San Francisco, California, USA.
Brian McMahonArctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, US Centers for Disease Control and Prevention (CDC), Anchorage, Alaska, USA.
Aaron HarrisDivision of Viral Hepatitis, Centers for Human Immunodeficiency Virus, Tuberculosis Prevention, Sexually Transmitted Diseases, and Viral Hepatitis, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
Nina WeisDepartment of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Copenhagen, Denmark.
Josefine Lundberg EderthDepartment of Public Health Analysis and Data Management, Unit for Epidemiological Monitoring, Public Health Agency of Sweden, Stockholm, Sweden.
Maria AxelssonDepartment of Public Health Analysis and Data Management, Unit for Epidemiological Monitoring, Public Health Agency of Sweden, Stockholm, Sweden.
Sigurdur OlafssonDepartment of Gastroenterology and Hepatology, Landspitali University Hospital, Reykjavik, Iceland.
Carla OsiowyViral Hepatitis and Bloodborne Pathogens National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.ORCID 0000-0002-5429-7220
Kristina TomasSti and Hepatitis Section | La Section Des Its Et Des Hépatites, Stbbi Surveillance Division | Division De La Surveillance Des ITSS, Public Health Agency of Canada | L'Agence De La Santé Publique Du Canada, Ottawa, Ontario, Canada.
Signe BollerupDepartment of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Copenhagen, Denmark.
Kirsi LiitsolaDepartment of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland.
Chris ArchibaldCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Hans BlystadNorwegian Institute of Public Health, Oslo, Norway.
Michael BruceArctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, US Centers for Disease Control and Prevention (CDC), Anchorage, Alaska, USA.
Leisha NolenArctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, US Centers for Disease Control and Prevention (CDC), Anchorage, Alaska, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis B virus (HBV) infection remains a global health threat. The World Health Organization (WHO) established a goal to eliminate HBV infection as a public health threat by 2030, and defined targets for key interventions to achieve that goal. We evaluated HBV burden and relevant national recommendations for progress towards WHO targets in circumpolar countries. Viral hepatitis experts of circumpolar countries were surveyed regarding their country's burden of HBV, achievement of WHO targets and national public health authority recommendations for HBV prevention and control. Eight of nine circumpolar countries responded. All countries continue to see new HBV infections. Data about HBV prevalence and progress in reaching WHO 2030 elimination targets are lacking. No country was able to report data for all seven WHO target measures. All countries have recommendations targeting the prevention of mother-to-child transmission. Only the USA and Greenland recommend universal birth dose vaccination. Four countries have recommendations to screen persons at high risk for HBV. Existing recommendations largely address prevention; however, recommendations for universal birth dose vaccination have not been widely introduced. Opportunities remain for the development of trackable targets and national elimination planning to screen and treat for HBV to reduce incidence and mortality.

Indexed as

Hepatitis BHepatitis B virusFemaleGlobal HealthHumansInfectious Disease Transmission, VerticalWorld Health OrganizationCircumpolar Viral Hepatitis Working GroupeliminationHepatitis B infectionpolicy surveypublic health policyvaccination recommendation

Identifiers

PMID34668463
PMCPMC8530492

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.